SpotSee recently acquired unique temperature indicator technologies and intellectual property from Sensor International, which supplies intelligent indicator technologies that can be integrated into various products, packaging, medical devices, and diagnostics.
These patented technologies are particularly useful in life science, food safety, and high-pressure pasteurization markets, SpotSee said.
“SpotSee sees a tremendous opportunity with the Sensor Indicator technologies because of its low-cost, time-temperature detection capabilities that can mimic spoilage experienced in vaccine vial monitoring, pharmaceuticals and food,” Tony Fonk, president and CEO of SpotSee, said in a news release. “We look forward to working with the Sensor Indicator team to develop and commercialize these unique technologies into real world applications.”
This is the second acquisition by SpotSee announced in May, following the addition of Marathon Products in San Leandro, California, earlier in the month. The goal is to develop the best patient-focused life science solutions, as well as products for food distribution monitoring, SpotSee reported.
The World Health Organization (WHO) mandates that manufacturers utilize vaccine vial monitors, enabling millions of vaccines to reach rural patients throughout the globe without spoilage. Through the acquisition of Sensor International, SpotSee will continue its development of key solutions to support the distribution and monitoring of vaccine and temperature sensitive medication.
According to the IQVIA Institute for Human Data Science, 30% of cold chain products are scrapped because of cold chain issues.
“SpotSee is a purpose-driven company, and we are motivated to create unique technologies that help solve a global health problem,” Fonk concluded. “We are proud of our role to help reduce waste in the pharmaceutical supply chain.
“Imagine if we had 30% more medicine to reach those in need.”